Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Activity of Bis-Carbamoyloxymethyl Derivatives of Pyrroles and Pyrrolizines against Human Tumor Xenografts in Nude Mice

Activity of Bis-Carbamoyloxymethyl Derivatives of Pyrroles and Pyrrolizines against Human Tumor... The activities of the pyrrolizines, Compounds I and II , and the pyrroles, Compounds IV and V , are reported in nude mouse-grown HT-29 human adenocarcinoma of the colon, DO 1 human oat carcinoma of the lung, and CL 1 human duct cell carcinoma of the breast (coded as CX-1, LX-1, and MX-1, respectively, by the National Cancer Institute). Compounds II and IV were active against all three experimental tumors; both compounds produced significant tumor regression in the human breast tumor xenograft and Compound IV caused tumor regression in the human lung tumor xenograft. 1 This investigation was supported by USPHS Grant CA-22935, awarded by the National Cancer Institute, Department of Health and Human Services. This is Paper 9 of the series entitled "Vinylogous Carbinolamine Tumor Inhibitors." For Paper 8 in this series, see Ref. 1. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cancer Research American Association of Cancer Research

Activity of Bis-Carbamoyloxymethyl Derivatives of Pyrroles and Pyrrolizines against Human Tumor Xenografts in Nude Mice

Cancer Research , Volume 42 (6): 2168 – Jun 1, 1982

Activity of Bis-Carbamoyloxymethyl Derivatives of Pyrroles and Pyrrolizines against Human Tumor Xenografts in Nude Mice

Cancer Research , Volume 42 (6): 2168 – Jun 1, 1982

Abstract

The activities of the pyrrolizines, Compounds I and II , and the pyrroles, Compounds IV and V , are reported in nude mouse-grown HT-29 human adenocarcinoma of the colon, DO 1 human oat carcinoma of the lung, and CL 1 human duct cell carcinoma of the breast (coded as CX-1, LX-1, and MX-1, respectively, by the National Cancer Institute). Compounds II and IV were active against all three experimental tumors; both compounds produced significant tumor regression in the human breast tumor xenograft and Compound IV caused tumor regression in the human lung tumor xenograft. 1 This investigation was supported by USPHS Grant CA-22935, awarded by the National Cancer Institute, Department of Health and Human Services. This is Paper 9 of the series entitled "Vinylogous Carbinolamine Tumor Inhibitors." For Paper 8 in this series, see Ref. 1.

Loading next page...
 
/lp/american-association-of-cancer-research/activity-of-bis-carbamoyloxymethyl-derivatives-of-pyrroles-and-eNnps3B6zM

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Association of Cancer Research
Copyright
Copyright © 1982 by the American Association for Cancer Research.
ISSN
0008-5472
Publisher site

Abstract

The activities of the pyrrolizines, Compounds I and II , and the pyrroles, Compounds IV and V , are reported in nude mouse-grown HT-29 human adenocarcinoma of the colon, DO 1 human oat carcinoma of the lung, and CL 1 human duct cell carcinoma of the breast (coded as CX-1, LX-1, and MX-1, respectively, by the National Cancer Institute). Compounds II and IV were active against all three experimental tumors; both compounds produced significant tumor regression in the human breast tumor xenograft and Compound IV caused tumor regression in the human lung tumor xenograft. 1 This investigation was supported by USPHS Grant CA-22935, awarded by the National Cancer Institute, Department of Health and Human Services. This is Paper 9 of the series entitled "Vinylogous Carbinolamine Tumor Inhibitors." For Paper 8 in this series, see Ref. 1.

Journal

Cancer ResearchAmerican Association of Cancer Research

Published: Jun 1, 1982

There are no references for this article.